SOPHiA GENETICS to Present at the 40th Annual J.P. Morgan Healthcare Conference

SOPHiA GENETICS (Nasdaq: SOPH) has announced that CEO Dr. Jurgi Camblong and CFO Ross Muken will present at the 40th Annual J.P.

Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH) has announced that CEO Dr. Jurgi Camblong and CFO Ross Muken will present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at 8:15 a.m. ET. The presentation will be accessible live and archived on their website. SOPHiA GENETICS is focused on data-driven medicine and operates the SOPHiA DDM™ Platform used by over 780 institutions worldwide.

Argus Session date unavailable

+2.14% session move Open Argus

Details

News Market Reaction – SOPH

The recorded move for SOPH in the trading session of this news was +2.14%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON and LAUSANNE, Switzerland, Dec. 29, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), announced today Chief Executive Officer and Co-Founder Dr. Jurgi Camblong and Chief Financial Officer Ross Muken, will participate in the upcoming 40^th Annual J.P. Morgan Healthcare Conference. The virtual presentation will begin at 8:15 a.m. ET/2:15 p.m. CET on Tuesday, January 11, 2022 and will be available live and archived on SOPHiAGENETICS.COM, in the Investor Relations section.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn and Instagram. Where others see data, we see answers.

Investor Contact:
Jennifer Pottage
Head of Investor Relations
Jpottage@sophiagenetics.com

Media Contact:
Eliza Bamonti
Director of Public Relations
Ebamonti@sophiagenetics.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the date and time of SOPHiA GENETICS' presentation at the J.P. Morgan Healthcare Conference?

SOPHiA GENETICS will present on January 11, 2022, at 8:15 a.m. ET.

Where can I watch the SOPHiA GENETICS conference presentation?

The presentation can be viewed live and archived on SOPHiA GENETICS' website.

Who are the executives presenting at the J.P. Morgan Healthcare Conference for SOPHiA GENETICS?

Dr. Jurgi Camblong (CEO) and Ross Muken (CFO) will be presenting.

What is the focus of SOPHiA GENETICS as a company?

SOPHiA GENETICS focuses on establishing data-driven medicine as a standard of care.

How many institutions use the SOPHiA DDM™ Platform?

The SOPHiA DDM™ Platform is currently used by over 780 institutions globally.